Rosmarinic acid prevents fibrillization and diminishes vibrational modes associated to β sheet in tau protein linked to Alzheimer's disease
Alzheimer's disease is a common tauopathy where fibril formation and aggregates are the hallmark of the disease. Efforts targeting amyloid-β plaques have succeeded to remove plaques but failed in clinical trials to improve cognition; thus, the current therapeutic strategy is at preventing tau a...
Saved in:
Main Authors: | Alberto Cornejo (Author), Felipe Aguilar Sandoval (Author), Leonardo Caballero (Author), Luis Machuca (Author), Patricio Muñoz (Author), Julio Caballero (Author), George Perry (Author), Alejandro Ardiles (Author), Carlos Areche (Author), Francisco Melo (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2017-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Neuronal Vulnerability of the Entorhinal Cortex to Tau Pathology in Alzheimer's Disease
by: Simi Zhang, et al.
Published: (2024) -
PBPK-PD modeling for the preclinical development and clinical translation of tau antibodies for Alzheimer's disease
by: Peter Bloomingdale, et al.
Published: (2022) -
INFLUÊNCIA DAS PROTEÍNAS BETA AMILOIDE E TAU NA DOENÇA DE ALZHEIMER
by: Fausto Pierdoná Guzen, et al.
Published: (2012) -
Tauvid™: The First FDA-Approved PET Tracer for Imaging Tau Pathology in Alzheimer's Disease
by: Caitlin V. M. L. Jie, et al.
Published: (2021) -
Traditional Chinese medicine in Alzheimer's disease: From the perspective of GSK-3β and Tau hyperphosphorylation
by: Mei Wang, et al.
Published: (2024)